The company said, “Building on previously announced initiatives, the Company plans to continue expanding its presence in international healthcare markets, including North America and Europe, through product commercialization, distribution partnerships, and healthcare service collaborations. Visionary intends to accelerate the commercialization of its RAMU anti-aging product line, targeting premium medical aesthetics and regenerative healthcare applications.The Company plans to further develop healthcare service platforms that combine medical aesthetics products, wellness services, and advanced biotechnology applications.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GV:
- Visionary Holdings signs $12M distribution agreement
- Visionary Holdings announces divestiture of non-core education business
- Visionary Holdings provides execution update on $9M sales contract
- Visionary Holdings establishes three subsidiaries in Qingdao, Wuxi, Wuhu
- Visionary Holdings regains compliance with Nasdaq periodic filing rule